Investing.com - Edwards Lifesciences (NYSE:EW) reported fourth quarter earnings that matched analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $1.17 on revenue of $977.7M. Analysts polled by Investing.com expected EPS of $1.17 on revenue of $976.31M. That compared to EPS of $0.94 on revenue of $888.5M in the same period a year earlier. The company had reported EPS of $1.07 on revenue of $921M in the previous quarter.
Edwards Lifesciences shares lost 1.42% to trade at $168.00 in after-hours trade following the report.
Edwards Lifesciences shares lost 1.42% to trade at $168.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 11.26%, outperforming the S&P 500 which is up 9.58% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar